Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Wiskott-Aldrich syndrome

Wiskott-Aldrich syndrome

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Wiskott-Aldrich syndrome

4 trials tracked for Wiskott-Aldrich syndrome: 2 in phase 3 or 4.

4Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 2
  1. Phase 4 A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency Completed
  2. Phase 3 Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. Completed
  3. Phase 2 Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Completed
  4. Phase 2 Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic review of neurological manifestations in Wiskott–Aldrich syndrome
Allergy & Immunology Meta-analysis
Systematic review of neurological manifestations in Wiskott–Aldrich syndrome At-a-Glance
This systematic review synthesized neurological manifestations in 32 patients with Wiskott–Aldrich syndrome. The authors report high case-fa…
A rare immune disorder called Wiskott-Aldrich syndrome can cause serious brain problems years after diagnosis, and some types are far more d…
Frontiers May 7, 2026